Laura Harbison
Family Medicine · Cameron, MONPI 1427239318
Payments from drug & device makers
Across 74 payments — averaging $19.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$185
- AbbVie$157
- AstraZeneca$115
- Pfizer$108
- Mylan Specialty L.p.$86
- Johnson & Johnson$72
- plus $702 from 20 others
What the payments were for
- Food & beverage$1,425100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,425 in reported general payments places this provider in the 70th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 82 | $102,180 |
| EliquisApixaban | 73 | $69,940 |
| JardianceEmpagliflozin | 28 | $29,306 |
| FarxigaDapagliflozin Propanediol | 41 | $24,949 |
| XareltoRivaroxaban | 31 | $19,291 |
| JanuviaSitagliptin Phosphate | 23 | $15,084 |
| MyrbetriqMirabegron | 23 | $10,120 |
| LinzessLinaclotide | 16 | $8,463 |
| Incruse ElliptaUmeclidinium Bromide | 19 | $7,041 |
| ZenpepLipase/Protease/Amylase | 12 | $5,630 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $3,739 |
| Potassium Chloride | 186 | $3,573 |
| Atorvastatin Calcium | 373 | $3,447 |
| Pantoprazole Sodium | 266 | $3,151 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 12 | $3,084 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $185 | $102,18082 claims |
| PfizerEliquis | $108 | $69,94073 claims |
| Boehringer IngelheimJardiance | $15 | $29,30628 claims |
| AstraZenecaFarxiga | $115 | $24,94941 claims |
| Johnson & JohnsonXarelto | $72 | $19,29131 claims |
| MerckJanuvia | $64 | $15,08423 claims |
| GSKIncruse Ellipta, Arexvy | $72 | $10,12531 claims |
| Astellas Pharma US IncMyrbetriq | $23 | $10,12023 claims |
| AbbVieLinzess | $157 | $8,46316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Cameron
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.